NCT02002819View on ClinicalTrials.gov

Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

October 16, 2014

Primary Completion Date

July 21, 2020

Study Completion Date

July 21, 2020

Conditions
Alzheimer's Disease
Interventions
DRUG

levetiracetam

Trial Locations (2)

55455

University of Minnesota, Minneapolis

94158

UCSF, San Francisco

All Listed Sponsors
lead

University of Minnesota

OTHER

NCT02002819 - Levetiracetam for Alzheimer's Disease-Associated Network Hyperexcitability | Biotech Hunter | Biotech Hunter